“Accelerate your plant innovation!” VEGEPOLYS VALLEY is launching the 7th edition of its competition dedicated to start-ups.
22 September 2022
MEET-UP Pharma: the 1st forum of the Healthcare Industry Professions in Auvergne.
14 June 2022
Hypercholesterolemia: Valbiotis announces the major success of the Phase II HEART clinical study.
9 June 2022
ON-LIGHT will take part on the 2nd Regional Research Days in the Hospital Centre, organized by Emile Roux Hospital Center of Puy-en-Velay on 23 and 24 June 2022.
5 April 2022
Clermont Innovation Week Roundtable: How can and should health and climate-conscious agricultural approaches create value in our territories?
1 April 2022
Le SMO Biopôle Clermont-Limagne publie son Panorama & chiffres Clés 2021.
14 February 2022
Valbiotis announces approval to launch the two Phase II/III INSIGHT and INSIGHT 2 clinical studies, the last step in the development of TOTUM•854 for the reduction of blood pressure.
21 December 2021
The EIB, with the support of the European Commission, is financing a €30 million loan for Carbios’ enzymatic recycling technology to support the Circular Economy.
17 December 2021
STRAINCHEM enters the semi-industrial phase with France Relance.
29 November 2021
Carbios receives support from the European Commission through the LIFE program.
19 November 2021
Valbiotis: preclinical results for TOTUM•070 in hypercholesterolemia, selected and presented at the American Heart Association (AHA) annual meeting.
11 October 2021
Pascal Mayer receives the prestigious breakthrough prize for his massive parallel sequencing technology codecovery.
25 May 2021
Valbiotis obtains patent for its active substance TOTUM-63 in China.
27 April 2021
Carbios and Michelin on their way to 100% sustainable tires.
12 April 2021
With its extension project supported by France Relance, the Icare group strengthens its development ambitions.
15 January 2021
Discover BIOLIFE ENTERPRISES special Biopôle Clermont-Limagne
You can revoke your consent at any time by using the "Revoke Consent" button.Revoke consent